rs727504721
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PM5PP5
The NM_206933.4(USH2A):c.821G>A(p.Arg274Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000013 in 1,613,050 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R274G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.821G>A | p.Arg274Gln | missense_variant | 5/72 | ENST00000307340.8 | NP_996816.3 | |
USH2A | NM_007123.6 | c.821G>A | p.Arg274Gln | missense_variant | 5/21 | NP_009054.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.821G>A | p.Arg274Gln | missense_variant | 5/72 | 1 | NM_206933.4 | ENSP00000305941 | P1 | |
USH2A | ENST00000366942.3 | c.821G>A | p.Arg274Gln | missense_variant | 5/21 | 1 | ENSP00000355909 | |||
USH2A | ENST00000674083.1 | c.821G>A | p.Arg274Gln | missense_variant | 5/73 | ENSP00000501296 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152076Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250898Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135602
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1460974Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 726798
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152076Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74276
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 02, 2024 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 36460718, 34948090, 27460420) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 274 of the USH2A protein (p.Arg274Gln). This variant is present in population databases (rs727504721, gnomAD 0.006%). This missense change has been observed in individual(s) with inherited retinal dystrophy and/or Usher syndrome (PMID: 27460420, 34948090, 36460718; Invitae). ClinVar contains an entry for this variant (Variation ID: 179225). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Not Available". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant disrupts the p.Arg274 amino acid residue in USH2A. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 28041643; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Retinitis pigmentosa 39 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 02, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 08, 2013 | Variant classified as Uncertain Significance - Favor Benign. The Arg274Gln varia nt in USH2A has not been reported in individuals with hearing loss or in large p opulation studies. The arginine (Arg) residue at position 274 is not well conser ved across species with cat and shrew having a glutamine (Gln) at that position. However, computational data (SIFT, PolyPhen2, AlignGVGD) provide conflicting pr edictions on the impact of the variant. In summary, the clinical significance of this variant cannot be determined with certainty; however based upon the conser vation data, we would lean towards a more likely benign role. - |
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Mar 20, 2018 | - - |
Usher syndrome type 2A Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Oct 14, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at